Cargando…
Directed differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6.1 factors in IPC progenitors
BACKGROUND: Induced pluripotent stem cells (iPSC) possess an enormous potential as both, scientific and therapeutic tools. Their application in the regenerative medicine provides new treatment opportunities for numerous diseases, including type 1 diabetes. In this work we aimed to derive insulin pro...
Autores principales: | Walczak, Maciej P., Drozd, Anna M., Stoczynska-Fidelus, Ewelina, Rieske, Piotr, Grzela, Dawid P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168869/ https://www.ncbi.nlm.nih.gov/pubmed/27998294 http://dx.doi.org/10.1186/s12967-016-1097-0 |
Ejemplares similares
-
Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system
por: Drozd, Anna M., et al.
Publicado: (2015) -
Regeneration difficulties in patients with FQAD can limit the use of iPSc-based cell therapy
por: Grot, Dagmara, et al.
Publicado: (2022) -
EGFR Activation Leads to Cell Death Independent of PI3K/AKT/mTOR in an AD293 Cell Line
por: Treda, Cezary, et al.
Publicado: (2016) -
Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1
por: Memon, Bushra, et al.
Publicado: (2018) -
Correction to: Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1
por: Memon, Bushra, et al.
Publicado: (2018)